Bohi F, Hottiger M
Biomedicines. 2024; 12(7).
PMID: 39062190
PMC: 11275100.
DOI: 10.3390/biomedicines12071617.
Jeon J, Lee K, Jang H, Yang K, Lee C, Ahn H
Sci Rep. 2024; 14(1):159.
PMID: 38167603
PMC: 10761972.
DOI: 10.1038/s41598-023-50630-2.
Garrett O, Whalen K
Front Microbiol. 2023; 14:1266972.
PMID: 37869665
PMC: 10587436.
DOI: 10.3389/fmicb.2023.1266972.
Jang H, Park E, Jung H, Kwon T
Am J Physiol Renal Physiol. 2023; 326(1):F69-F85.
PMID: 37855039
PMC: 11194055.
DOI: 10.1152/ajprenal.00144.2023.
Zong W, Gong Y, Sun W, Li T, Wang Z
Cancers (Basel). 2022; 14(17).
PMID: 36077699
PMC: 9454564.
DOI: 10.3390/cancers14174162.
Poly(ADP-Ribose) Polymerase Inhibition as a Promising Approach for Hepatocellular Carcinoma Therapy.
Paturel A, Hall J, Chemin I
Cancers (Basel). 2022; 14(15).
PMID: 35954469
PMC: 9367559.
DOI: 10.3390/cancers14153806.
Fueling genome maintenance: On the versatile roles of NAD in preserving DNA integrity.
Ruszkiewicz J, Burkle A, Mangerich A
J Biol Chem. 2022; 298(6):102037.
PMID: 35595095
PMC: 9194868.
DOI: 10.1016/j.jbc.2022.102037.
Therapeutic Potentials of Poly (ADP-Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting.
Wang Y, Pleasure D, Deng W, Guo F
Adv Sci (Weinh). 2021; 9(5):e2102853.
PMID: 34935305
PMC: 8844485.
DOI: 10.1002/advs.202102853.
Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses.
Boehi F, Manetsch P, Hottiger M
Cell Discov. 2021; 7(1):104.
PMID: 34725336
PMC: 8560908.
DOI: 10.1038/s41421-021-00323-9.
The Intra- and Extra-Telomeric Role of TRF2 in the DNA Damage Response.
Imran S, Yazid M, Cui W, Lokanathan Y
Int J Mol Sci. 2021; 22(18).
PMID: 34576063
PMC: 8470803.
DOI: 10.3390/ijms22189900.
Nuclear ADP-ribosylation drives IFNγ-dependent STAT1α enhancer formation in macrophages.
Gupte R, Nandu T, Kraus W
Nat Commun. 2021; 12(1):3931.
PMID: 34168143
PMC: 8225886.
DOI: 10.1038/s41467-021-24225-2.
Autoregulates Its Expression in the Pulmonary Endothelium After Endotoxin Stimulation in a Histone Acetylation-Dependent Manner.
Xia S, Yu W, Menden H, Younger S, Sampath V
Front Cell Dev Biol. 2021; 9:657662.
PMID: 34017833
PMC: 8129010.
DOI: 10.3389/fcell.2021.657662.
PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis.
Wasyluk W, Zwolak A
J Inflamm Res. 2021; 14:1827-1844.
PMID: 33986609
PMC: 8110256.
DOI: 10.2147/JIR.S300679.
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19.
Ge Y, Tian T, Huang S, Wan F, Li J, Li S
Signal Transduct Target Ther. 2021; 6(1):165.
PMID: 33895786
PMC: 8065335.
DOI: 10.1038/s41392-021-00568-6.
A novel predicted ADP-ribosyltransferase-like family conserved in eukaryotic evolution.
Wyzewski Z, Gradowski M, Krysinska M, Dudkiewicz M, Pawlowski K
PeerJ. 2021; 9:e11051.
PMID: 33854844
PMC: 7955679.
DOI: 10.7717/peerj.11051.
PARP Traps Rescue the Pro-Inflammatory Response of Human Macrophages in the In Vitro Model of LPS-Induced Tolerance.
Pietrzak J, Gronkowska K, Robaszkiewicz A
Pharmaceuticals (Basel). 2021; 14(2).
PMID: 33671709
PMC: 7926882.
DOI: 10.3390/ph14020170.
Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals.
Wu R, Li S, Hudlikar R, Wang L, Shannar A, Peter R
Free Radic Biol Med. 2020; 179:328-336.
PMID: 33359432
PMC: 8222414.
DOI: 10.1016/j.freeradbiomed.2020.12.007.
Poly(ADP-ribose) Polymerase 1 (PARP1) restrains MyoD-dependent gene expression during muscle differentiation.
Matteini F, Andresini O, Petrai S, Battistelli C, Rossi M, Maione R
Sci Rep. 2020; 10(1):15086.
PMID: 32934320
PMC: 7493885.
DOI: 10.1038/s41598-020-72155-8.
The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors.
Sobczak M, Zyma M, Robaszkiewicz A
Cells. 2020; 9(9).
PMID: 32900001
PMC: 7565932.
DOI: 10.3390/cells9092040.
Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases.
Pazzaglia S, Pioli C
Cells. 2019; 9(1).
PMID: 31877876
PMC: 7017201.
DOI: 10.3390/cells9010041.